How could SFOR get a non-toxic loan and does the loan have
How could SFOR get a non-toxic loan and does the loan have a message to investors without actually saying it?
Here it is from the latest fins:
Note 10 – Subsequent Events
"In July 2017, the Company issued a convertible note payable for $175,000, bearing interest at 10% per annum, and maturing in July 2018. At the option of the holder, beginning seven months from the date issued, the note is convertible into shares of common stock of the Company at a price per share discount of 42% of the lowest closing market price of the Company’s common stock for the twenty days preceding a conversion notice. The Company determined that the conversion feature of the note was not fixed, and will record the fair value of the conversion feature of approximately $190,000 as a derivative liability."
My opinion is 2 fold (certainly loaded with info) and please correct me if anyone disagrees:
1) What lender would actually stick their neck out under these terms for a pink sheet ticker? Most lenders go for toxic lending if there is too much risk. The company is losing money but there must be something around the corner. A lender has the right to insider info. that can't be disclosed publicly to determine the risk and the terms and conditions of the loan. The loan appears to be to hold SFOR over until the new investors close the deal with SFOR by the end of Sept. So this lender must know about deals and/or settlement negotiations. 10% with no conversion rights in the 1st. seven months means low risk LOAN. IMO.
2) SFOR can pay (my interpretation of the paragraph above, I do not have any more details of the loan terms and conditions) this loan off for a reasonable 10% (non toxic) if they do it before Feb. 2018 (within 7 months). The lender can not convert until after 7 months have gone by. So if SFOR gets major deals done and/or settlement money and/or money from the $9milly (due by 9/2020) before Feb.2018, the loan will only cost 10%.
The way this loan was written plays along with what Kay has been saying about major deals during the 2nd half of 2017. Kay has the opportunity to pay this note off without hurting shareholders if one of these catalysts come to fruition. But even converted shouldn't hurt shareholders.
ONE THING NO ONE CAN DENY IS THAT SFOR IS PUSHING HARD TO GET MANY THINGS DONE.
LOOKING FOR ALOT OF ACTION OVER THE NEXT TWO TO THREE MONTHS.
IMO
2
Zerify Inc (ZRFY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...
Continue Reading
A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...
Continue Reading
Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...
Continue Reading
Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...
Continue Reading
Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...
Continue Reading
Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...
Continue Reading
Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...
Continue Reading
Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...
Continue Reading
Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...
Continue Reading
Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...
Continue Reading
Top 5 Most Recently Viewed Articles
A New Chapter in Pharmacy Care Alright, folks, CVS Health just threw its cowboy hat into the ring with a grand opening of its first pharmacy-focused spot down in south Houston. This ain't your typical retail maze—it's a compact little number designed to form tighter bonds between patient and pharmacist, and it's opening the doors to a shift in pharmacy care access. The...
Continue Reading
New Exploration Permit Approved for Rokmaster Resources Rokmaster Resources Corp. (TSXV: RKR) is thrilled to announce the recent approval of a three-year exploration permit critical for their operations on the Fox-Coconut Property. This milestone marks an important step in the company's strategic plan, enabling them to embark on expansive exploration activities aimed at...
Continue Reading
Gleim Aviation Showcases Innovative Training Solutions Gleim Aviation, known for its leadership in aviation education, is excited to unveil cutting-edge training technologies at EAA AirVenture Oshkosh, making waves in the aviation community. Visit Us at Hangar A, Booth 1104 From July 21 to July 27, Gleim Aviation invites flight training professionals, pilots, and aviation...
Continue Reading
Lennox Expands Its HVAC Offerings with New Acquisition Lennox, a prominent name in energy-efficient climate control solutions, has taken a significant step by acquiring the HVAC Division of NSI Industries. This notable acquisition includes the respected Duro Dyne and Supco brands, a move designed to enhance Lennox’s parts and supplies portfolio, offering better services...
Continue Reading
Quantum BioPharma Announces Private Placement Initiative Quantum BioPharma Ltd. (NASDAQ: QNTM) has embarked on a new phase of capital acquisition through a non-brokered private placement. This strategic move will involve issuing class A multiple voting shares (MVS) priced at $50 each, targeting an impressive total of $600 million in gross proceeds aimed at bolstering the...
Continue Reading